Holdings
JNL/Mellon Healthcare Sector Fund
As of Jun 30, 2026, JNL/Mellon Healthcare Sector Fund reported 138 positions worth US$2.67B. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 330K | US$396M | −11,334 | Jun 30, 2026 |
| Johnson & Johnson | 992K | US$252M | −39,847 | Jun 30, 2026 |
| Abbvie Inc. | 727K | US$183M | −29,225 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 373K | US$155M | −15,000 | Jun 30, 2026 |
| Merck & Company, Inc. | 989K | US$127M | −74,830 | Jun 30, 2026 |
| Amgen Inc. | 221K | US$80.2M | −8,898 | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 153K | US$76.8M | −7,903 | Jun 30, 2026 |
| Abbott Laboratories | 716K | US$65M | −28,780 | Jun 30, 2026 |
| Gilead Sciences, Inc. | 511K | US$64.6M | −20,536 | Jun 30, 2026 |
| Intuitive Surgical, Inc. | 145K | US$57.8M | −5,839 | Jun 30, 2026 |